160 related articles for article (PubMed ID: 17977733)
21. DNA sequence recognition by bispyrazinonaphthalimides antitumor agents.
Carrasco C; Joubert A; Tardy C; Maestre N; Cacho M; Braña MF; Bailly C
Biochemistry; 2003 Oct; 42(40):11751-61. PubMed ID: 14529286
[TBL] [Abstract][Full Text] [Related]
22. Novel C8-linked pyrrolobenzodiazepine (PBD)-heterocycle conjugates that recognize DNA sequences containing an inverted CCAAT box.
Brucoli F; Hawkins RM; James CH; Wells G; Jenkins TC; Ellis T; Hartley JA; Howard PW; Thurston DE
Bioorg Med Chem Lett; 2011 Jun; 21(12):3780-3. PubMed ID: 21570842
[TBL] [Abstract][Full Text] [Related]
23. Binding of f-PIP, a pyrrole- and imidazole-containing triamide, to the inverted CCAAT box-2 of the topoisomerase IIalpha promoter and modulation of gene expression in cells.
Le NM; Sielaff AM; Cooper AJ; Mackay H; Brown T; Kotecha M; O'Hare C; Hochhauser D; Lee M; Hartley JA
Bioorg Med Chem Lett; 2006 Dec; 16(24):6161-4. PubMed ID: 17011187
[TBL] [Abstract][Full Text] [Related]
24. Site-specific inhibition of transcription factor binding to DNA by a metallointercalator.
Odom DT; Parker CS; Barton JK
Biochemistry; 1999 Apr; 38(16):5155-63. PubMed ID: 10213621
[TBL] [Abstract][Full Text] [Related]
25. Mitosis-specific MPM-2 phosphorylation of DNA topoisomerase IIalpha is regulated directly by protein phosphatase 2A.
Escargueil AE; Larsen AK
Biochem J; 2007 Apr; 403(2):235-42. PubMed ID: 17212588
[TBL] [Abstract][Full Text] [Related]
26. Regulation of SOX3 gene expression is driven by multiple NF-Y binding elements.
Krstic A; Mojsin M; Stevanovic M
Arch Biochem Biophys; 2007 Nov; 467(2):163-73. PubMed ID: 17910945
[TBL] [Abstract][Full Text] [Related]
27. Nuclear factor-Y binding to the topoisomerase IIalpha promoter is inhibited by both the p53 tumor suppressor and anticancer drugs.
Joshi AA; Wu Z; Reed RF; Suttle DP
Mol Pharmacol; 2003 Feb; 63(2):359-67. PubMed ID: 12527807
[TBL] [Abstract][Full Text] [Related]
28. Nuclear Localization and Gene Expression Modulation by a Fluorescent Sequence-Selective p-Anisyl-benzimidazolecarboxamido Imidazole-Pyrrole Polyamide.
Kiakos K; Pett L; Satam V; Patil P; Hochhauser D; Lee M; Hartley JA
Chem Biol; 2015 Jul; 22(7):862-75. PubMed ID: 26119998
[TBL] [Abstract][Full Text] [Related]
29. Sequence specific recognition of DNA by tailor-made hairpin conjugates of achiral seco-cyclopropaneindoline-2-benzofurancarboxamide and pyrrole-imidazole polyamides.
Price CA; Lingerfelt BM; Handl HL; Kiakos K; Hartley JA; Lee M
Bioorg Med Chem Lett; 2005 Jun; 15(12):3151-6. PubMed ID: 15876536
[TBL] [Abstract][Full Text] [Related]
30. Identification of an NF-Y/HMG-I(Y)-binding site in the human IL-10 promoter.
Lin SC
Mol Immunol; 2006 Mar; 43(9):1325-31. PubMed ID: 16256199
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biophysical evaluation of minor-groove binding C-terminus modified pyrrole and imidazole triamide analogs of distamycin.
Brown T; Taherbhai Z; Sexton J; Sutterfield A; Turlington M; Jones J; Stallings L; Stewart M; Buchmueller K; Mackay H; O'hare C; Kluza J; Nguyen B; Wilson D; Lee M; Hartley JA
Bioorg Med Chem; 2007 Jan; 15(1):474-83. PubMed ID: 17035029
[TBL] [Abstract][Full Text] [Related]
32. Role of an inverted CCAAT element in human topoisomerase IIalpha gene expression in ICRF-187-sensitive and -resistant CEM leukemic cells.
Morgan SE; Beck WT
Mol Pharmacol; 2001 Feb; 59(2):203-11. PubMed ID: 11160854
[TBL] [Abstract][Full Text] [Related]
33. Position-specific trapping of topoisomerase II by benzo[a]pyrene diol epoxide adducts: implications for interactions with intercalating anticancer agents.
Khan QA; Kohlhagen G; Marshall R; Austin CA; Kalena GP; Kroth H; Sayer JM; Jerina DM; Pommier Y
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12498-503. PubMed ID: 14523238
[TBL] [Abstract][Full Text] [Related]
34. The structure-based design, synthesis, and biological evaluation of DNA-binding amide linked bisintercalating bisanthrapyrazole anticancer compounds.
Hasinoff BB; Zhang R; Wu X; Guziec LJ; Guziec FS; Marshall K; Yalowich JC
Bioorg Med Chem; 2009 Jul; 17(13):4575-82. PubMed ID: 19457675
[TBL] [Abstract][Full Text] [Related]
35. Topoisomerase IIalpha inhibition following DNA transfection greatly enhances random integration in a human pre-B lymphocyte cell line.
Toyoda E; Kurosawa A; Kamekawa H; Adachi N
Biochem Biophys Res Commun; 2009 May; 382(3):492-6. PubMed ID: 19285952
[TBL] [Abstract][Full Text] [Related]
36. C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo.
Linka RM; Porter AC; Volkov A; Mielke C; Boege F; Christensen MO
Nucleic Acids Res; 2007; 35(11):3810-22. PubMed ID: 17526531
[TBL] [Abstract][Full Text] [Related]
37. Modifying the N-terminus of polyamides: PyImPyIm has improved sequence specificity over f-ImPyIm.
Brown T; Mackay H; Turlington M; Sutterfield A; Smith T; Sielaff A; Westrate L; Bruce C; Kluza J; O'Hare C; Nguyen B; Wilson WD; Hartley JA; Lee M
Bioorg Med Chem; 2008 May; 16(9):5266-76. PubMed ID: 18353654
[TBL] [Abstract][Full Text] [Related]
38. Unique base-step recognition by a platinum-acridinylthiourea conjugate leads to a DNA damage profile complementary to that of the anticancer drug cisplatin.
Budiman ME; Alexander RW; Bierbach U
Biochemistry; 2004 Jul; 43(26):8560-7. PubMed ID: 15222767
[TBL] [Abstract][Full Text] [Related]
39. Physical and structural basis for the strong interactions of the -ImPy- central pairing motif in the polyamide f-ImPyIm.
Buchmueller KL; Bailey SL; Matthews DA; Taherbhai ZT; Register JK; Davis ZS; Bruce CD; O'Hare C; Hartley JA; Lee M
Biochemistry; 2006 Nov; 45(45):13551-65. PubMed ID: 17087509
[TBL] [Abstract][Full Text] [Related]
40. Regulation of the human topoisomerase IIalpha gene promoter in confluence-arrested cells.
Isaacs RJ; Harris AL; Hickson ID
J Biol Chem; 1996 Jul; 271(28):16741-7. PubMed ID: 8663303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
